Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China
Authors:
Top Cited Papers
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 26 (6) , 767-772
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaNew England Journal of Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyThe Lancet, 2020
- Molecular Evolution of Human Coronavirus GenomesTrends in Microbiology, 2017
- Epidemiology, Genetic Recombination, and Pathogenesis of CoronavirusesTrends in Microbiology, 2016
- KDIGO Clinical Practice Guidelines for Acute Kidney InjuryNephron Clinical Practice, 2012
- Acute Respiratory Distress SyndromeJAMA, 2012
- Exacerbated Innate Host Response to SARS-CoV in Aged Non-Human PrimatesPLOS Pathogens, 2010
- The Immunopathogenesis of Sepsis in Elderly PatientsClinical Infectious Diseases, 2005